Literature DB >> 2136621

Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia.

D Powars1, R J Adams, F T Nichols, P Milner, S Charache, S Sarnaik.   

Abstract

Clinical and necropsy findings in 11 patients with sickle cell anemia (SS) indicate that intracranial hemorrhage (IH) is a delayed sequela of the same vasculopathy that causes cerebral infarction during childhood. Evidence of prior cerebral infarction during childhood included hemiparesis, seizures, an episode of coma, or mental retardation. Computerized tomography (CT) scans showed cerebral infarcts with lucent areas and dilated ventricles or cerebral atrophy. CT or magnetic resonance imaging (MRI) scans after the intracranial hemorrhage demonstrated intraventricular or intracerebral hemorrhages. Angiography or autopsy in seven patients showed widespread vascular occlusion and narrowing of arterial vessels. Moyamoya with internal carotid artery occlusion was identified in two cases. At the time of the IH, three patients were being treated with prophylactic transfusion regimens. We hypothesize that the central nervous system vasculopathy progresses over time and that arterial narrowing in both large and small vessels secondary to endothelial hyperplasia is followed by neovascularization and hemorrhage. Recognition of this pattern of delayed intracranial hemorrhage following cerebral infarction should encourage more intensive evaluation aimed at developing rational interventional therapy prior to a terminal intracranial hemorrhage.

Entities:  

Mesh:

Year:  1990        PMID: 2136621

Source DB:  PubMed          Journal:  J Assoc Acad Minor Phys        ISSN: 1048-9886


  10 in total

Review 1.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

Review 2.  Stroke in children with sickle cell anaemia: aetiology and treatment.

Authors:  C H Pegelow
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  How I treat and manage strokes in sickle cell disease.

Authors:  Adetola A Kassim; Najibah A Galadanci; Sumit Pruthi; Michael R DeBaun
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

4.  Extradural Hemorrhage: A rare Complication and Manifestation of Stroke in Sickle Cell Disease.

Authors:  Muhammad J Azhar
Journal:  Oman Med J       Date:  2010-10

5.  Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia.

Authors:  Baba Inusa; Maddalena Casale; Caroline Booth; Sebastian Lucas
Journal:  BMJ Case Rep       Date:  2014-10-21

6.  Stroke in Children with Sickle Cell Disease.

Authors:  Fenella J. Kirkham; Michael R. DeBaun
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

7.  Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.

Authors:  Mark C Walters; Karen Hardy; Sandie Edwards; Thomas Adamkiewicz; James Barkovich; Francoise Bernaudin; George R Buchanan; Nancy Bunin; Roswitha Dickerhoff; Roger Giller; Paul R Haut; John Horan; Lewis L Hsu; Naynesh Kamani; John E Levine; David Margolis; Kwaku Ohene-Frempong; Melinda Patience; Rupa Redding-Lallinger; Irene A G Roberts; Zora R Rogers; Jean E Sanders; J Paul Scott; Keith M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-12       Impact factor: 5.742

8.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

9.  A rare case of spontaneous bilateral extradural hematoma in a sickle cell disease child.

Authors:  Sunil K Patra; Sudhanshu S Mishra; Srikant Das
Journal:  J Pediatr Neurosci       Date:  2012-01

10.  HbSC Disease and Spontaneous Epidural Hematoma with Kernohan's Notch Phenomena.

Authors:  Meera Yogarajah; Chidozie Charles Agu; Bhradeev Sivasambu; Mark A Mittler
Journal:  Case Rep Hematol       Date:  2015-10-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.